Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor
ANTIOXIDANTS（2023）
关键词
NAFLD,NASH,PPAR subtypes,dual/pan agonist,ligand-binding domain,X-ray crystallography
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要